SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-20-013797
Filing Date
2020-02-10
Accepted
2020-02-10 17:27:36
Documents
1
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv537827_sc13ga.htm SC 13G/A 52948
  Complete submission text file 0001104659-20-013797.txt   54446
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87481 | Film No.: 20593085
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 908-673-9000
Celgene European Investment Co LLC (Filed by) CIK: 0001577650 (see all company filings)

IRS No.: 900587060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A